Jose Estevam

1.1k total citations
16 papers, 754 citations indexed

About

Jose Estevam is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Jose Estevam has authored 16 papers receiving a total of 754 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Hematology and 5 papers in Oncology. Recurrent topics in Jose Estevam's work include Multiple Myeloma Research and Treatments (9 papers), Protein Degradation and Inhibitors (8 papers) and Peptidase Inhibition and Analysis (3 papers). Jose Estevam is often cited by papers focused on Multiple Myeloma Research and Treatments (9 papers), Protein Degradation and Inhibitors (8 papers) and Peptidase Inhibition and Analysis (3 papers). Jose Estevam collaborates with scholars based in United States, Japan and Spain. Jose Estevam's co-authors include Paul G. Richardson, Parameswaran Hari, S. Vincent Rajkumar, Shaji Kumar, A. Keith Stewart, Robert M. Rifkin, Natalie S. Callander, Ian W. Flinn, Jeffrey L. Wolf and Stephen J. Noga and has published in prestigious journals such as Blood, PLoS ONE and The Lancet Oncology.

In The Last Decade

Jose Estevam

15 papers receiving 732 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jose Estevam United States 11 627 566 361 82 45 16 754
Roberto Mina Italy 15 564 0.9× 483 0.9× 380 1.1× 84 1.0× 37 0.8× 51 679
Valeria Magarotto Italy 12 565 0.9× 669 1.2× 345 1.0× 61 0.7× 47 1.0× 32 837
PR Greipp United States 11 577 0.9× 414 0.7× 289 0.8× 114 1.4× 38 0.8× 12 635
Loredana Santo United States 9 456 0.7× 383 0.7× 326 0.9× 59 0.7× 83 1.8× 23 633
S. Mattox United States 6 672 1.1× 423 0.7× 300 0.8× 123 1.5× 56 1.2× 7 742
Luis Palomera Spain 10 596 1.0× 465 0.8× 345 1.0× 115 1.4× 50 1.1× 25 671
Jeana Cromer United States 6 802 1.3× 557 1.0× 413 1.1× 64 0.8× 63 1.4× 6 870
Mary McKenney United States 8 769 1.2× 655 1.2× 411 1.1× 124 1.5× 36 0.8× 11 871
Norbert Pescosta Italy 11 455 0.7× 420 0.7× 276 0.8× 62 0.8× 55 1.2× 23 614
Mihaela Popa McKiver United States 6 419 0.7× 320 0.6× 399 1.1× 51 0.6× 122 2.7× 12 568

Countries citing papers authored by Jose Estevam

Since Specialization
Citations

This map shows the geographic impact of Jose Estevam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jose Estevam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jose Estevam more than expected).

Fields of papers citing papers by Jose Estevam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jose Estevam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jose Estevam. The network helps show where Jose Estevam may publish in the future.

Co-authorship network of co-authors of Jose Estevam

This figure shows the co-authorship network connecting the top 25 collaborators of Jose Estevam. A scholar is included among the top collaborators of Jose Estevam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jose Estevam. Jose Estevam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Paiva, Bruno, Irene Manrique, Meletios Α. Dimopoulos, et al.. (2022). MRD dynamics during maintenance for improved prognostication of 1280 patients with myeloma in the TOURMALINE-MM3 and -MM4 trials. Blood. 141(6). 579–591. 25 indexed citations
2.
3.
Estevam, Jose, et al.. (2021). Development and validation of a high‐parameter mass cytometry workflow to decipher immunomodulatory changes in celiac disease. Cytometry Part B Clinical Cytometry. 100(1). 92–102. 4 indexed citations
4.
Abadier, Michael, Jose Estevam, Deborah Berg, & Eric R. Fedyk. (2020). Mezagitamab Induces Immunomodulatory Effect in Patients with Relapsed/Refractory Multiple Myeloma (RRMM). Blood. 136(Supplement 1). 9–9. 4 indexed citations
5.
Fedyk, Eric R., Lin‐Pierre Zhao, Annelize Koch, et al.. (2020). Safety, tolerability, pharmacokinetics and pharmacodynamics of the anti‐CD38 cytolytic antibody TAK‐079 in healthy subjects. British Journal of Clinical Pharmacology. 86(7). 1314–1325. 35 indexed citations
6.
Fedyk, Eric R., Neeraja Idamakanti, Jia Chen, et al.. (2019). The Binding of CD38 Therapeutics to Red Blood Cells and Platelets Subverts Depletion of Target Cells. Blood. 134(Supplement_1). 3136–3136. 1 indexed citations
7.
Gallery, Melissa, Daniel P. Bradley, Pamela P. Brauer, et al.. (2018). A monomethyl auristatin E-conjugated antibody to guanylyl cyclase C is cytotoxic to target-expressing cells in vitro and in vivo. PLoS ONE. 13(1). e0191046–e0191046. 20 indexed citations
8.
Miguel, Jesús F. San, Ivan Špıčka, María‐Victoria Mateos, et al.. (2018). A phase I/II dose-escalation study investigating all-oral ixazomib-melphalan-prednisone induction followed by single-agent ixazomib maintenance in transplant-ineligible newly diagnosed multiple myeloma. Haematologica. 103(9). 1518–1526. 18 indexed citations
9.
Fedyk, Eric R., et al.. (2018). A Single Administration of the Cytolytic CD38 Antibody TAK-079 to Healthy Subjects: Tolerability, Pharmacokinetics and Pharmacodynamics. Blood. 132(Supplement 1). 3249–3249. 6 indexed citations
10.
Richardson, Paul G., Craig C. Hofmeister, Cara A. Rosenbaum, et al.. (2018). Twice‐weekly ixazomib in combination with lenalidomide‐dexamethasone in patients with newly diagnosed multiple myeloma. British Journal of Haematology. 182(2). 231–244. 27 indexed citations
11.
Wyant, Tim, Jose Estevam, Lili Yang, & Maria Rosario. (2015). Development and validation of receptor occupancy pharmacodynamic assays used in the clinical development of the monoclonal antibody vedolizumab. Cytometry Part B Clinical Cytometry. 90(2). 168–176. 24 indexed citations
12.
13.
14.
Kumar, Shaji, Ian W. Flinn, Paul G. Richardson, et al.. (2012). Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma. Blood. 119(19). 4375–4382. 318 indexed citations
15.
Estevam, Jose, Hadi Danaee, Ray Liu, et al.. (2010). Validation of a flow cytometry based G2M delay cell cycle assay for use in evaluating the pharmacodynamic response to Aurora A inhibition. Journal of Immunological Methods. 363(2). 135–142. 12 indexed citations
16.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roberto Mina Breakdown of academic impact, for papers by Valeria Magarotto Breakdown of academic impact, for papers by PR Greipp Breakdown of academic impact, for papers by Loredana Santo Breakdown of academic impact, for papers by S. Mattox Breakdown of academic impact, for papers by Luis Palomera Breakdown of academic impact, for papers by Jeana Cromer Breakdown of academic impact, for papers by Mary McKenney Breakdown of academic impact, for papers by Norbert Pescosta Breakdown of academic impact, for papers by Mihaela Popa McKiver
Rankless by CCL
2026